🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Flu D-TIV

Found 95 matching trials

A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

PHASE2

"Multimeric-001" (M-001) has been recently developed, containing conserved,...

Status

Completed

Location

Hadassah medical center

Start Date

2011-08

Trial ID

NCT01419925

Treatments Being Tested

Two Multimeric-001 administrations followed by TIV One administration of Multimeric-001 followed by TIV One administration of adjuvanted M-001 followed by TIV One administration of placebo followed by TIV

Structured Review: To Optimise Management and Prevent Harm in COPD

Background: Chronic obstructive pulmonary disease (COPD) is a serious lung...

Status

Recruiting

Location

Northumbria NHS Foundation Trust

Start Date

2026-03-11

Trial ID

NCT07460154

Treatments Being Tested

Sputum sample Venepuncture Lung function test Medical history and physical examination Blood pressure BMI HRCT of chest ECG Echo Subject Questionnaires Research Questionnaires Influenza Vaccines Pneumococcal Vaccine RSV F vaccine (0.5mL injection)Oxygen saturation (+/- ABG)DXA Education

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

PHASE3

The purpose of this study is to evaluate the safety and immunogenicity of G...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-04-29

Trial ID

NCT02369341

Treatments Being Tested

Fluarix Tetra

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

PHASE1

The purpose of this study is to learn about how the flu and COVID vaccines ...

Status

Completed

Location

Anaheim Clinical Trials, LLC

Start Date

2025-02-10

Trial ID

NCT06821061

Treatments Being Tested

Investigational Influenza Vaccine Investigational COVID-19 Vaccine Investigational Influenza and COVID-19 Combination Vaccine Licensed Influenza Vaccine 1 Licensed Influenza Vaccine 2 Licensed Influenza Vaccine 3 Licensed COVID-19 Vaccine

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

N/A

The purpose of this exploratory, retrospective laboratory study is to asses...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-10-26

Trial ID

NCT02415842

Treatments Being Tested

Serum samples

COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses

N/A

The study is to investigate the antibody response in the blood and saliva o...

Status

Completed

Location

Department of Health, Economics and Health Directorate Canton Basel-Land

Start Date

2020-04-10

Trial ID

NCT04483908

Treatments Being Tested

blood draw fingertip tests for POC assays saliva collection collection of swabs

A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

PHASE1

The purpose of this study is to assess the reactogenicity, safety and immun...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-09-08

Trial ID

NCT03275389

Treatments Being Tested

D-SUIV cH8/1N1+AS03 D-SUIV cH5/1N1+AS03 D-SUIV cH11/1N1+AS03 D-SUIV cH8/1N1+AS01 D-SUIV cH5/1N1+AS01 D-SUIV cH11/1N1+AS01 D-SUIV cH8/1N1 D-SUIV cH5/1N1 D-SUIV cH11/1N1 Placebo Fluarix Quadrivalent

Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

PHASE2

A 1-year multicenter, randomized, single-blinded, phase II trial, stratifie...

Status

Completed

Location

Hôpital Henri Mondor

Start Date

2009-10

Trial ID

NCT01008813

Treatments Being Tested

adjuvanted A(H1N1)v influenza vaccine non-adjuvanted A(H1N1)v influenza vaccine

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

PHASE2

The purpose of this study is to characterize the immunogenicity and safety ...

Status

Withdrawn

Location

GSK Investigational Site

Start Date

2011-01

Trial ID

NCT01045564

Treatments Being Tested

GSK influenza virus H5N1 vaccine 1557484A

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

PHASE3

This Phase 3 study evaluates the safety, immunogenicity and lot-to lot cons...

Status

Completed

Location

Optimal Research, LLC

Start Date

2016-07-11

Trial ID

NCT02839330

Treatments Being Tested

aH5N1c Placebo

Previous Next